marijuana stocks

GW Pharmaceuticals Continues To Rally: A Technical Look

GW Pharmaceuticals Plc (NASDAQ:GWPH) shares were trading higher by $2.20 (2.5 percent) at $97.86 in Monday’s session. The darling of the marijuana sector is following through on Friday’s impressive nearly $11.00 rally ($84.58 to $95.66). It should be noted Friday’s rally took place on extremely high volume for the issue of nearly two million shares vs. its 20-day average of 325,000.

Investors may be anticipating positive results as the company is set to release additional Epidiolex data at the American Academy of Neurology that should inform developments in other orphan epilepsy. Over the past year, the issue has fluctuated primarily based on news concerning the drug and not so much on developments related to marijuana.

See Also: 15 Marijuana Stocks To Watch In 2015

After a bit off profit-taking off the open, it quickly found support just $0.16 from its opening price ($94.23 vs. $94.39) before ripping north once again. At time of writing, it easily surpassed Friday’s high ($95.92), reaching $98.43 before taking a breather.

The all-time high for the issue was made in July 2014, at the pinnacle of the “pot stock” mania at $111.46, before cascading to $58.16 in October.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$NVLX Gives Update on Partner Austrianova

Nuvilex’s Partner Austrianova Successfully Completes First Live Cell Encapsulation in New Facility…

Innovative Industrial Properties, Inc. (IIPR) Properties Declares Third Quarter 2023 Dividends

Innovative Industrial Properties Declares Third Quarter 2023 Dividends Innovative Industrial Properties, Inc.…

ParcelPal Technology Inc. (PTNYF) (PKG.CN) Announces Delivery Agreement with Aphria Inc.

ParcelPal Announces Delivery Agreement with Aphria Inc. ParcelPal Technology Inc. (“ParcelPal” or…

$GWPH SHAREHOLDER ALERT

IMPORTANT GW PHARMACEUTICALS SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP…